Short-term efficacy and safety of the synchronous neoadjuvant chemoradiotherapy with paclitaxel plus carboplatin in stage III adenocarcinoma of esophagogastric junction.
Short-term efficacy and safety of synchronous neoadjuvant chemoradiotherapy with Paclitaxel plus carboplatin in stage III adenocarcinoma of the esophagogastric junction.